We estimate that the President and CEO of CABOT CORP ($CBT), Sean D. Keohane, received a compensation of $9,307,883 in 2025. This is a decrease of -3.14% from an estimated $9,600,154 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on January 27, 2026. Note that parsing errors may occur.
You can track $CBT on Quiver Quantitative's $CBT stock dashboard.
$CBT Stock Insider Trading Activity
$CBT Stock insiders have traded $CBT stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CBT stock by insiders over the last 6 months:
- SEAN D KEOHANE (President and CEO) has made 0 purchases and 4 sales selling 114,436 shares for an estimated $9,072,094.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CBT Stock Hedge Fund Activity
We have seen 165 institutional investors add shares of $CBT Stock stock to their portfolio, and 209 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 386,514 shares (+186.7%) to their portfolio in Q3 2025, for an estimated $29,394,389
- LIGHTROCK NETHERLANDS B.V. added 317,934 shares (+227.3%) to their portfolio in Q4 2025, for an estimated $21,072,665
- COPELAND CAPITAL MANAGEMENT, LLC removed 215,412 shares (-29.1%) from their portfolio in Q3 2025, for an estimated $16,382,082
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 204,975 shares (+61.6%) to their portfolio in Q3 2025, for an estimated $15,588,348
- AMERICAN CENTURY COMPANIES INC added 140,665 shares (+8.4%) to their portfolio in Q3 2025, for an estimated $10,697,573
- QUBE RESEARCH & TECHNOLOGIES LTD removed 126,370 shares (-42.3%) from their portfolio in Q3 2025, for an estimated $9,610,438
- VICTORY CAPITAL MANAGEMENT INC added 102,764 shares (+259.2%) to their portfolio in Q3 2025, for an estimated $7,815,202
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CBT Stock Analyst Ratings
Wall Street analysts have issued reports on $CBT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Underweight" rating on 11/28/2025
- Mizuho issued a "Outperform" rating on 11/17/2025
To track analyst ratings and price targets for $CBT Stock, check out Quiver Quantitative's $CBT forecast page.
$CBT Stock Price Targets
Multiple analysts have issued price targets for $CBT recently. We have seen 3 analysts offer price targets for $CBT in the last 6 months, with a median target of $74.0.
Here are some recent targets:
- Joshua Spector from UBS set a target price of $74.0 on 01/12/2026
- John Roberts from Mizuho set a target price of $80.0 on 12/18/2025
- Jeffrey Zekauskas from JP Morgan set a target price of $54.0 on 11/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
